Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-075902
Filing Date
2025-05-21
Accepted
2025-05-21 18:00:04
Documents
1
Period of Report
2025-05-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6140
  Complete submission text file 0000950170-25-075902.txt   8242
Mailing Address 9620 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Huang James (Reporting) CIK: 0001573160 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 25974239

Mailing Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320
Business Address 1280 RANCHO CONEJO BLVD THOUSAND OAKS CA 91320 805-623-4211
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MAPLES CORPORATE SERVICES LIMITED BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address C/O MAPLES CORPORATE SERVICES LIMITED BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 86 21 60252100
Panacea Innovation Ltd (Reporting) CIK: 0002010692 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 25974240